Susquehanna International Group, LLP Jaguar Health, Inc. Transaction History

Susquehanna International Group, LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.08 - $809.55 $23,313 - $236 Million	-291,416 Reduced 86.36%	46,013 $4,000
Q3 2022 Nov 14, 2022	BUY	$0.17 - $765.0 $57,362 - $258 Million	337,429 New	337,429 $53,000
Q1 2022 May 16, 2022	SELL	$0.38 - $1.07 $97,094 - $273,398	-255,513 Reduced 74.03%	89,638 $64,000
Q4 2021 Feb 14, 2022	BUY	$1.03 - $2.48 $94,353 - $227,180	91,605 Added 36.13%	345,151 $359,000
Q3 2021 Nov 15, 2021	BUY	$2.14 - $4.95 $542,588 - $1.26 Million	253,546 New	253,546 $576,000

Ticker JAGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 119,861,000
Market Cap $133M
Description
Jaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with gastrointestinal distress, specifically chronic, and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It markets Mytesi for the symptomatic relief of noninfecti...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.